UBS AM’s Morphic Holding, Inc. Common Stock MORF Stock Holding History

UBS AM’s Portfolio MORF Stock Details MORF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-46,688	Closed	-$1.59M	–	2885
2024 Q2	$1.59M	Buy	46,688 +26,807	+135%	+$794K	﹤0.01%	2116
2024 Q1	$700K	Hold	19,881	–	–	﹤0.01%	2179
2023 Q4	$574K	Buy	19,881 +7,927	+66%	+$189K	﹤0.01%	2275
2023 Q3	$274K	Sell	11,954 -1,658	-12%	-$87K	﹤0.01%	2455
2023 Q2	$512K	Hold	13,612	–	–	﹤0.01%	2309
2023 Q1	$512K	Buy	+13,612	New	+$502K	﹤0.01%	2309
2022 Q2	–	Sell	-11,728	Closed	-$471K	–	2794
2022 Q1	$471K	Hold	11,728	–	–	﹤0.01%	2482
2021 Q4	$556K	Hold	11,728	–	–	﹤0.01%	2514
2021 Q3	$664K	Hold	11,728	–	–	﹤0.01%	2365
2021 Q2	$673K	Buy	11,728 +1,243	+12%	+$68.4K	﹤0.01%	2411
2021 Q1	$663K	Buy	+10,485	New	+$481K	﹤0.01%	2284

Other funds holding MORF

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Hoey Investments Coatesville, Pennsylvania $693M AUM 34.99% 1-Year Est. Return

UBS AM's MORF Position: Q3 2024 in Review

UBS AM sold out of Morphic Holding, Inc. Common Stock (MORF) in Q3 2024, closing a stake of 46,688 shares — an estimated $1.59M sold.

UBS AM first reported a position in MORF in Q1 2021 and held it in 11 quarters. The position peaked at $1.59M in Q2 2024. 2 funds tracked by Wall St. Rank hold MORF as of Q3 2024.

UBS AM reported no remaining Morphic Holding, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
UBS AM sold 46,688 Morphic Holding, Inc. Common Stock shares in Q3 2024, an estimated $1.59M.
UBS AM first reported a position in Morphic Holding, Inc. Common Stock in Q1 2021 and held it in 11 quarters.
UBS AM's Morphic Holding, Inc. Common Stock position peaked at $1.59M in Q2 2024.
2 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q3 2024.

Based on UBS AM's 13F filing for Q3 2024, filed 14 Nov 2024.